Correction to: Leukemia (2017) 31, 2717–2725; doi:https://doi.org/10.1038/leu.2017.143; published online 23 May 2017
This article was originally published under a CC BY-NC-ND 4.0 license, but has now been made available under a CC BY 4.0 license. The PDF and HTML versions of the paper have been modified accordingly.
Additional information
The online version of the original article can be found at https://doi.org/10.1038/leu.2017.143
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Pearson, S., Williamson, A., Blance, R. et al. Erratum: Proteomic analysis of JAK2V617F-induced changes identifies potential new combinatorial therapeutic approaches. Leukemia 32, 574 (2018). https://doi.org/10.1038/leu.2017.333
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2017.333
